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Abstract: The catenin beta-1 (CTNNB1) gene, encoding a sub-unit of the cadherin/catenin 
protein complex that is involved in the Wnt signalling pathway important for proper 
interneuron development, is considered to be causative for the rare autosomal dominant 
mental retardation syndrome, formerly called MRD19 but later renamed neurodevelopmental 
disorder with spastic diplegia and visual defects (NEDSDV). Its main characteristics are 
moderate to severe intellectual disability (ID), disruptive autistic behaviours, microcephaly, 
absent or limited speech, facial dysmorphisms, peripheral hypertonia/spasticity, motor delay 
and visual defects. So far, 35 patients have been reported with a de novo loss-of-function 
variant in CTNNB1. In two other patients, a deletion comprising the full gene was found. 
Four out of the 37 patients were of adult age (range: 27–51 years), while the majority was 
infant or adolescent (range: 0–20 years). Here, a 32-year-old severely intellectually disabled 
female patient is described in whom exome sequencing disclosed a de novo heterozygous 
splice site variant in the CTNNB1 gene [Chr3(GRCh37): g.41267064G>T; NM_001904.3: 
23. c.734+1G>T; r. spl?]. Somatic investigation disclosed significant microcephaly and 
minor facial dysmorphisms. Neurological examination demonstrated severe kyphoscoliosis, 
distal spastic tetraparesis, especially of the legs with increased tendon reflexes and bilateral 
Babinski sign, resulting in severely impaired walking capability with a broad-based gait. 
Apart from strabismus, no ophthalmological abnormalities were found. Here, the reported 
variant in the CTNNB1 gene was not published earlier nor is included in the international 
databases. This specific variant is considered to be causative for the severe ID, autism and 
the somato-neurological phenotype of the patient and corresponds with a diagnosis of 
NEDSDV. 
Keywords: heterozygous splice site variant, CTNNB1, NEDSDV, autism, intellectual 
disability, distal spastic tetraparesis
Introduction
A small decade ago, diagnostic exome sequencing in a large group of patients with 
intellectual disability (ID) by De Ligt and coworkers yielded five candidate genes 
associated with ID including the β-catenin (CTNNB1) gene (OMIM: 116806) 
located on 3p22.1 in three patients.1 In all, main characteristics were severe ID, 
absent or limited speech, microcephaly, and spasticity with severely impaired 
walking ability. These observations led CTNNB1 to be postulated as a novel ID 
gene causing autosomal dominant mental retardation type 19 (MRD19). In a mouse 
model, it has been demonstrated that haploinsufficiency of this gene leads to 
disturbances in the regulation of dendritic branching and causes craniofacial 
abnormalities and cognitive dysfunction providing functional evidence for a causal 
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relation between haploinsufficiency of CTNNB1 and the 
corresponding ID phenotype in humans.2
So far, 35 patients have been reported with a (de novo) 
loss-of-function variant of CTNNB1.1–6 In two other 
patients, a deletion comprising the full gene was found.3,7 
Four out of this total of 37 patients were of adult age (27, 
27, 29, and 51 years) while the majority were infant or 
adolescent (age range: 0–20 years). By systematic analysis 
of the earlier findings on clinical features, Kuechler and 
coworkers also identified multiple ocular abnormalities 
such as strabismus and hyperopia often to be present.3 
Therefore, the MRD19 syndrome was renamed into neu-
rodevelopmental disorder with spastic diplegia and visual 
defects (NEDSDV; OMIM: #615075). Findings on retinal 
detachment and proliferative vitreoretinopathy in a very 
limited number of patients seem to corroborate this.8,9
Summarizing, main clinical features in patients with 
CTNNB1-haploinsufficiency comprise moderate to severe 
ID, behavioural abnormalities including autistic traits, 
microcephaly, craniofacial dysmorphisms, truncal hypoto-
nia, peripheral hypertonia/spasticity, motor delay, speech 
impairment and visual defects.3
We here report in detail the developmental trajectory of 
a 32-years-old intellectually disabled adult female, who 
was referred for the assessment and treatment of persistent 
severe challenging behaviours.
Patients and Methods
Ethical Aspects
Assessments were performed at the Raphael Institute 
Scorlewald, Centre for People with Intellectual 
Disabilities, in Schoorl, the Netherlands under supervision 
of consultants from the Dutch Centre for Consultation and 
Expertise, Utrecht, The Netherlands, that provided ethical 
approval for publication (CCE Directorate Approval letter 
#01082020). In addition, both parents gave written 
informed consent for publication including the picture of 
the patient (consent form dated April 2020). Both approval 
letters were provided to the Editorial Board.
Case Description
The patient is the second child of non-consanguineous 
healthy parents. Pregnancy and birth were unremarkable. 
Height, weight and head circumference at birth were 
50cm, 3200gr and 33,5cm, respectively. She has one 
older brother and a younger sister and brother, all healthy.
Already in her first months, there were marked feeding 
problems and her parents noticed lack of eye contact, a 
general refusal of communication and delay of develop-
ment, reason why she was examined by a pediatrician at 
the age of seven months. Physical examination demon-
strated striking microcephaly (head circumference: 
38.5cm; <P0.6), short stature (63cm; P2), markedly low 
weight (5800gr; P0.6) without, however, any dysmorph-
isms or other abnormalities. Ultrasound and X-ray of the 
skull as well as EEG were all normal. No explanation for 
the developmental delay was found and physical therapy 
was advised to stimulate motor development.
About four months later, re-examination revealed stra-
bismus convergens alternans, head and truncal instability 
as well as the tendency to overstretch. Height, weight and 
head circumference were now 69.5cm (<P10), 7570gr (P3) 
and 40.5cm (<P0.6), respectively. Ophthalmological 
examination refined the diagnosis of strabismus into left 
sided strabismus convergens. Again, no further explana-
tion could be provided.
Aged 17 months, she was hospitalized for two weeks 
because of the suspicion of a metabolic disease that, how-
ever, was excluded. Examination disclosed absent sucking 
reflex, nearly lacking contact, suboptimal head balance, 
absent truncal balance, and inability to sit, stand or walk. 
Between her second and fifth years, she underwent several 
follow-up examinations. Chromosomal analysis at age two 
revealed a normal 46, XX karyotype. During that period 
general growth followed the same pattern with, eg, head 
circumference of 45cm (<P2) at age three. At neurological 
examination, tendon reflexes were normal. Concerning 
motor development, she did not show any balance while 
standing even with support. X-pelvis demonstrated marked 
right hip dysplasia for which a pavlik harness was pre-
scribed. Now, facial dysmorphic features and autistic 
behaviours were noticed. All these years, she underwent 
intensive physical and logopedic therapy which led to 
gradual but only limited improvement of motor skills, 
speech and language.
The delayed milestones became more apparent after 
the birth of her younger sister and brother, reason why 
she, at about seven years of age, was hospitalized for six 
months to a pedagogic observation clinic. At that time, 
there were challenging and ritualistic behaviours with 
temper tantrums and mood instability. Speech was 
restricted to 2–4 words and the developmental level of 
receptive and expressive language was about 3–4 years. 
There were marked hypotonia with an uncoordinated 
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global movement pattern, persisting mild overstretch, and 
valgus deformity. Because of the latter, aged 9, the patient 
successfully underwent bilateral extra-articular subtalar 
arthrodesis after which her walking pattern stabilized in 
that she was able to walk with support for a short distance. 
Nevertheless, she needed a wheeled walker and was par-
tially wheelchair bound. Communication was hampered by 
frequent crying, involuntary gestures, and head banging. 
Behavioural observation revealed clear autistic traits. 
Special education and individual guidance within a struc-
tured environment were recommended.
At the age of 12, she was examined at a university 
clinic for child neurology. MRI scanning of the brain 
disclosed no abnormalities and a cause for her develop-
mental delay and motor dysfunction could not be estab-
lished. Shortly thereafter, a diagnosis of autism spectrum 
disorder was made at an outpatient department for child 
psychiatry.
During the following years, she lived at her parent’s 
home, followed specialized education for some years, 
stayed during daytime within an activity center of an 
institute for people with intellectual disabilities where 
she was employed with simple work at the pottery and 
remained several weekends at the institute. During adoles-
cence, her significant right convex thoracolumbar scoliosis 
increased markedly (40º), leading to a right structural 
kyphosis. In addition, she developed a spastic atactic 
walking pattern.
Aged 21, she was institutionalized permanently 
because of progressive problems with walking (nearly 
completely wheelchair bound) and intensifying of challen-
ging behaviours with temper tantrums, anger, and scream-
ing especially in situations with less structure and 
predictability. Over the following years, the patient parti-
cipated in various simple daycare activities at the institute 
for people with ID while staying at her parent’s home 
during the weekends. She was treated symptomatically 
with 0.1mg haloperidol twice daily and, at night, 40mg 
pipamperone in combination with 2mg melatonin. In addi-
tion, 800IE cholecalciferol once daily was prescribed.
Investigations
Somatic investigation at the age of 32 years disclosed 
significant microcephaly with a head circumference of 
50cm (P<0.6). Height and weight were 150cm and 
50.1kg, respectively. She was almost completely wheel-
chair bound and there was no active language apart from 
limited 3 to 4 words sentences. Her eye movements were 
not always well coordinated with intermittent strabismus. 
Her behaviour showed clear autistic traits and she was not 
fully toilet trained with respect to urine continence. There 
were mild facial dysmorphisms, including divergent stra-
bismus, thin lips, small alae nasi, full nasal tip, short 
philtrum, pointed chin, and slightly upslanted palpebral 
fissures (right>left) (Figure 1). As assessed with the 
Vineland Adaptive Behaviour Scale (VABS10), develop-
mental age scores on domains of communication, daily 
activities, socialization, and motor skills were 34, 44, 18 
and 16 months, respectively. Social-emotional develop-
ment as measured by the Dutch scale for emotional 
Figure 1 Clinical photographs of the patient at age 32 years showing mild facial dysmorphic features including divergent strabismus left eye, thin lips, small alae nasi, full nasal 
tip, short philtrum, pointed chin, and slightly upslanted palpebral fissures (right>left).
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development in people with intellectual disability (SEO- 
R11) corresponded with a developmental age of 18 months. 
With the revised scale for autism and related disorders 
(AVZ-R12), a total score of 16 was established (scores 
between 10 and 19 are indicative for autism). In addition, 
the total score on the Autism Diagnostic Observation 
Schedule (ADOS-213) of 27 (cut off: 9) corroborated a 
diagnosis of autism.
Neurological examination demonstrated truncal hypo-
tonia with severe kyphoscoliosis, mild intention tremor of 
both arms and distal spastic tetraparesis of the arms and 
legs, most pronounced at the lower extremities with 
increased tendon reflexes and bilateral Babinski sign. 
This neurological condition resulted in severely impaired 
walking capability in that she was, with support, able to 
take a few steps with a broad-based gait, only. Apart from 
strabismus, ophthalmologic evaluation showed no irregu-
larities, especially no vitreoretinopathy. Relevant hemato-
logical (eg, white blood count and thrombocytes) and 
biochemical parameters (eg, vitamin status, thyroid and 
liver parameters, glucose, and lipid spectrum) were all 
normal. MRI scanning of the brain disclosed no 
abnormalities.
Whole exome sequencing analysis was performed as 
described before.14 Essentially, DNA was sequenced on 
an Illumina HiSeq system after exome enrichment using 
the Agilent SureSelectXT Human All Exon 50Mb Kit. 
Reads were aligned to the Hg19 reference genome with 
BWA and variants were called using GATK and anno-
tated using an in-house developed pipeline. Data analy-
sis/filtering was performed essentially based on allele 
frequencies and mutation severity. This analysis demon-
strated a heterozygous splice donor site variant in the 
CTNNB1 gene [Chr3(GRCh37): g.41267064G>T; 
NM_001904.3: c.734+1G>T; r. spl?]. Subsequent tar-
geted Sanger sequencing analysis of the patient and 
both her parents showed that this concerns a de novo 
variant (see Supplementary figure for the Sanger 
sequencing electropherograms of the index and her par-
ents). This specific variant in the CTNNB1 gene has not 
been described before in the literature, but another var-
iant of the same splice donor site was reported in 2019 
in a patient with both severe ID and visual defects.6 The 
de novo CTNNB1 splice variant is considered to be 
causative for the severe ID and the clinical phenotype 
of the patient and is corresponding with a diagnosis of 
NEDSDV without, however, the vitreoretinopathy.
Outcome and Follow-Up
After extensive multidisciplinary discussion of the etiolo-
gical diagnosis and the potential neurological conse-
quences, ie, slow progression of the spastic atactic 
paraparesis especially of the legs, it was decided to focus 
individualized daily guidance as much as possible to both 
the patients autistic behaviour repertoire and her slowly 
progressive neurological dysfunctions. This approach 
resulted in a significant reduction of her challenging beha-
viours, in particular aggression, temper tantrums and anxi-
eties. Although the effectiveness of medication was 
doubtful, the symptomatic psychopharmacotherapy was 
kept unchanged.
Discussion
Here, an adult severely intellectually disabled female 
patient, aged 32, is described with a de novo heterozygous 
CTNNB1 variant that, to the best of our knowledge, has 
not been published earlier nor is included in the interna-
tional DECIPHER database or present in our inhouse 
database. Her main phenotypical characteristics include 
ID, mild facial dysmorphic features, severe speech and 
language impairment, microcephaly, truncal hypotonia, 
progressive distal peripheral spasticity leading to broad- 
based ataxic gait, and strabismus. In addition, mild over-
stretch was present as well as severe thoracolumbar 
kyphoscoliosis. Whereas the first decades of the develop-
mental trajectory of the patient were dominated by the 
above described somato/neurological abnormalities, from 
young adulthood and up, behavioural abnormalities and 
psychopathology within the autism spectrum became more 
prominent.
While this set of characteristics is fully compatible 
with those as described by both Kuechler and Kharbanda 
and their coworkers,3,5 in the present patient, for the first 
time, the results of extensive formal assessment of beha-
viour and psychopathology are reported confirming an 
AVZ-R and ADOS-compliant diagnosis of autism. This 
observation is in line with the report by Dong and associ-
ates who showed that loss-of-function of CTTNB1 in mice 
leads to behaviours showing similarity to autism, like 
significantly impaired object recognition and social inter-
actions as well as elevated repetitive behaviours.15
Conclusion
As the case presented here demonstrates, medical profes-
sionals should at present consider whole-exome 
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sequencing as the starting point in etiological investiga-
tion, especially in older patients with so far unexplained 
ID with or without neurological and/or somatic comorbid-
ities. This may be of great importance to elucidate course 
and prognosis of newly discovered genetic disorders. In 
the here presented patient, haploinsufficiency of CTNNB1 
is responsible for the craniofacial/ID/somato-neurological 
phenotypes and may be crucially involved in the gradual 
behavioural development from autistic traits to definite 
autism that necessitates permanent adjustment of daily 
guidance.
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